Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies ; volume:19 ; number:5 ; day:27 ; month:7 ; year:2017 ; pages:1499-1512 ; date:9.2017
The AAPS journal / American Association of Pharmaceutical Scientists ; 19, Heft 5 (27.7.2017), 1499-1512, 9.2017
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Creator
-
Tsamandouras, Nikolaos
- Contributor
-
Chen, Wen Li Kelly
Edington, Collin D.
Stokes, Cynthia L.
Griffith, Linda G.
Cirit, Murat
SpringerLink (Online service)
- DOI
-
10.1208/s12248-017-0122-4
- URN
-
urn:nbn:de:1111-201711052899
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsamandouras, Nikolaos
- Chen, Wen Li Kelly
- Edington, Collin D.
- Stokes, Cynthia L.
- Griffith, Linda G.
- Cirit, Murat
- SpringerLink (Online service)
Other Objects (12)
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
In vitro optimization of microdialysis for pharmacokinetic applications
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Liver organoids: an in vitro 3D model for liver cancer study
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149
Liver microsystems in vitro for drug response
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
In vitro optimization of microdialysis for pharmacokinetic applications
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Liver organoids: an in vitro 3D model for liver cancer study
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149
Liver microsystems in vitro for drug response
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
In vitro optimization of microdialysis for pharmacokinetic applications
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Liver organoids: an in vitro 3D model for liver cancer study
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149